Prion diseases, or transmissible spongiform encephalopathies (TSEs), are neurodegenerative disorders that include Creutzfeldt-Jakob disease (CJD) in humans, scrapie in sheep and goats, and bovine spongiform encephalopathy (BSE) in cattle. TSEs are characterized by accumulation of an abnormal isoform of the host-encoded prion protein (PrP^C^), termed PrP^Sc^.

A novel human prion disease, variant CJD, was reported in 1995 and postulated to be caused by eating beef infected with BSE. Biologic and molecular analyses provided evidence that the same agent was involved in BSE and variant CJD ([@R1]*,*[@R2]). Evidence of sheep and goat susceptibility to BSE ([@R3]) and discovery of natural BSE infections in 2 goats ([@R4]*,*[@R5]) prompted the European Commission to increase the search for BSE infections in small ruminants. Although the BSE agent can be recognized by biologic strain typing in conventional mice ([@R2]), large-scale testing of small ruminants required molecular tests able to discriminate BSE from the most common TSEs of small ruminants.

Molecular criteria used to discriminate BSE from scrapie are based on the low molecular weight of proteinase K--treated PrP^Sc^ (PrP^res^) ([@R6]*--*[@R8]), a high proportion of the diglycosylated PrP^Sc^ ([@R1]*,*[@R6]*,*[@R8]), and poor or absent binding with antibodies directed at N-terminal epitopes ([@R8]*--*[@R10]). This last characteristic was fundamental in developing the discriminatory methods currently approved for surveillance in Europe ([@R11]).

The experimental scrapie isolate CH1641 reportedly shares molecular features with experimental sheep BSE ([@R7]), although lack of transmissibility of CH1641 to conventional mice in comparison to successful transmission of BSE provided evidence that CH1641 and BSE are caused by distinct prion agents. A few natural isolates have been described in sheep, showing molecular ([@R10]*,*[@R12]) and biologic ([@R13]) similarities to CH1641, and were named CH1641-like. Subtle pathologic differences were exploited to distinguish these CH1641-like isolates from BSE by immunohistochemical ([@R5]*,*[@R10]) and biochemical analyses by glycoform profiling ([@R8]*,*[@R10]). However, routine testing by using discriminatory Western blot (WB) methods does not easily distinguish CH1641 and CH1641-like isolates from BSE ([@R8]*,*[@R12]). We report 2 new CH1641-like isolates; analyze the conformational stability of CH1641-like isolates, BSE, and classical scrapie; and show that a reliable molecular differentiation of these 3 TSE sources is possible by an improved discriminatory WB method.

The Study
=========

During 2009--2010, we analyzed conformational stability of PrP^Sc^ from sheep TSE isolates by using a conformational stability and solubility assay (CSSA) that we developed ([@R14]). We showed that CSSA could reveal strain-specified PrP^Sc^ conformational stability in sheep isolates because it enabled discrimination of Nor98 from classical scrapie isolates ([@R14]). Scrapie isolates had GdnHCl~1/2~ values (the concentration of guanidine hydrochloride able to dissolve half the insoluble PrP^Sc^ aggregates in a brain homogenate) of 2.0 mol/L--2.3 mol/L; Nor98 isolates were less stable (1.3--1.4 mol/L GdnHCl). We thus sought to determine the conformational stability of PrP^Sc^ aggregates ([Technical Appendix](#SD1){ref-type="local data"}) derived from CH1641 and BSE strains ([Table 1](#T1){ref-type="table"}), including one (TR316211) of the few CH1641-like field isolates described so far ([@R10]*,*[@R12]*,*[@R13]). Two other CH1641-like isolates (99--454 and 99--321) were found in a retrospective analysis of sheep scrapie cases in France.

###### Transmissible spongiform encephalopathy isolates analyzed by conformational stability and solubility assay\*

  Source                 Identification no.   PrP genotype†   GdnHCl~1/2~, mol/L ± SD‡
  ---------------------- -------------------- --------------- --------------------------
  Natural isolates                                            
  Scrapie                ES/8/10/2            ARQ/ARQ         2.19 ± 0.18
  CH1641-like            99--454              VRQ/VRQ         2.00 ± 0.06
                         99--321              VRQ/VRQ         2.41 ± 0.49
                         TR316211             ARQ/ARQ         2.82 ± 0.08
  Experimental samples                                        
  CH1641                 241/74               AxQ/AxQ         2.07 ± 0.05
  Sheep BSE              301/16§              ARQ/ARQ         \>4
                         301/44§              ARQ/ARQ         \>4
                         302/90¶              ARQ/ARQ         3.8; \>4; \>4

\*PrP, prion protein; GdnHCL~1/2~, guanidine hydrochloride at a concentration able to dissolve half the insoluble aggregates in a brain homogenate; BSE, bovine spongiform encephalopathy. †Amino acids at codons 136, 154 and 171. ‡Each sample was analyzed [\>]{.ul}3 times. §Intracerebral transmission. ¶Oral transmission.

Classical scrapie included as control displayed a GdnHCl~1/2~ value (2.2 mol/L) in the range of previously analyzed isolates. CH1641 (provided by N. Hunter, Institute for Animal Health, Edinburgh, Scotland) and CH1641-like isolates showed conformational stabilities close to classical scrapie, with GdnHCl~1/2~ values of 2.0--2.8 mol/L. In contrast, PrP^Sc^ from experimental sheep BSE ([@R15]) clearly showed higher conformational stability, with GdnHCl~1/2~ values \>3.8 mol/L ([Table 1](#T1){ref-type="table"}). These results suggest experimental sheep BSE might have a stronger resistance to denaturation than do most natural sheep scrapie isolates.

Because the discriminatory methods based on differential PrP^Sc^ N-terminal proteinase K (PK) cleavage ([@R11]) do not enable a clear-cut discrimination of CH1641-like from BSE ([@R12]), we investigated the potential of denaturation with GdnHCl as a further discriminatory strategy within the framework of the Istituto Superiore di Sanità discriminatory WB ([@R11]). To this aim, samples were untreated or treated with 3.5 mol/L GdnHCl before PK digestion and WB analysis with SAF84 and P4 monoclonal antibodies ([Figure 1](#F1){ref-type="fig"}). This method was set up by analyzing representative scrapie, BSE, and CH1641 samples ([Figure 1](#F1){ref-type="fig"}). As expected, BSE and CH1641 were poorly detected by P4, in contrast to classical scrapie. Treatment with 3.5 M GdnHCl, however, nearly abolished PK resistance of PrP^Sc^ from classical scrapie and CH1641, but not from sheep BSE, thus also enabling discrimination of CH1641 from BSE.

![Representative Western blot showing the differential N-terminal proteinase K cleavage (monoclonal antibodies SAF84 vs. P4) and the susceptibility to denaturation of different transmissible spongiform encephalopathy isolates. Samples are indicated according to [Table 2](#T2){ref-type="table"}: classical scrapie isolates (Sc1, Sc2, Sc3, Sc4); experimental CH1641 (Ch1); CH1641-like isolates (Ch2, Ch3, Ch4); experimental sheep bovine spongiform encephalopathy by intracerebral transmission (Bs1) and oral transmission (Bs2, Bs3, Bs4, Bs5); natural goat isolate (Bs6). All samples were pretreated (+) or not treated (-) with 3.5 mol/L guanidine hydrochloride for 1 h at 37°C and then diluted to a final concentration of 0.35 mol/L guanidine hydrochloride, before digestion with proteinase K according to the Istituto Superiore di Sanità discriminatory method. Replica blots were probed with SAF84 (top) and P4 (bottom). Molecular weights are indicated on the right. GdnHCl, guanidine hydrochloride.](10-1215-F1){#F1}

We then analyzed a larger set of samples ([Table 2](#T2){ref-type="table"}), including natural BSE in a goat ([Figure 1](#F1){ref-type="fig"}). These experiments confirmed the higher resistance to denaturation of BSE samples, irrespective of the species, PrP genotype, and route of inoculation, compared with all other samples ([Figure 1](#F1){ref-type="fig"}). When the antibody ratio and the denaturation ratio were measured and plotted as a scattergraph, classical scrapie, CH1641, and BSE isolates clustered into 3 distinct groups ([Figure 2](#F2){ref-type="fig"}, panel A): 1) scrapie isolates displayed antibody ratios \<2 and denaturation ratios were 0.02--0.13; 2) CH1641 samples had antibody ratios \>2 and denaturation ratios were 0.06--0.29; and 3) BSE samples had antibody ratios \>2, but denaturation ratios were \>0.51.

###### Transmissible spongiform encephalopathy samples analyzed by discriminatory Western blot\*

  Source                 Identification no.   PrP genotype†   Blot lane
  ---------------------- -------------------- --------------- -----------
  Natural isolates                                            
  Scrapie                ES16/10/10           ARQ/ARQ         Sc1
                         ES16/10/11           ARQ/ARQ         Sc2
                         ES16/10/12           ARQ/ARQ         Sc3
                         ES12/10/1            ARQ/ARQ         
                         ES12/10/2            ARQ/ARQ         
                         ES12/10/3            ARQ/ARQ         Sc4
  CH1641-like            99--454              VRQ/VRQ         Ch2
                         99--321              VRQ/VRQ         Ch4
                         TR316211             ARQ/ARQ         Ch3
  Goat BSE               CH636                                Bs6
  Experimental samples                                        
  CH1641                 241/74               AxQ/AxQ         Ch1
  Sheep BSE              301/16‡              ARQ/ARQ         Bs1
                         301/44‡              ARQ/ARQ         
                         302/87§              ARQ/ARQ         Bs3
                         302/130§             ARQ/ARQ         Bs4
                         302/64§              ARQ/AHQ         Bs5
                         302/90§              ARQ/ARQ         Bs2

\*Blot lanes shown in [Figure 1](#F1){ref-type="fig"}. PrP, prion protein; BSE, bovine spongiform encephalopathy. †Amino acids at codons 136, 154 and 171. ‡Intracerebral transmission. §Oral transmission.

![A) Scattergraph of antibody ratio and denaturation ratio obtained from each sample in [Table 2](#T2){ref-type="table"}, showing discrimination of scrapie, CH1641, CH1641-like, and bovine spongiform encephalopathy (BSE) samples. The antibody ratio is the SAF84/P4 ratio of the chemiluminescence signal relative to the SAF84/P4 ratio of the control scrapie loaded in each blot ([Technical Appendix](#SD1){ref-type="local data"}). The denaturation ratio, obtained from the SAF84 blot, is the ratio between the chemiluminescence signal with 3.5 mol/L and that with 0 mol/L. The vertical dashed line refers to the cutoff value of the antibody ratio, according to the Istituto Superiore di Sanità discriminatory Western blot (antibody ratio 2). The horizontal dashed line (denaturation ratio 0.4) shows the separation of BSE samples from all other transmissible spongiform encephalopathy sources. B) Scattergraph of proportions of diglycosylated and monoglycosylated PrPres bands from samples in [Table 2](#T2){ref-type="table"}. Results were obtained from guanidine hydrochloride--untreated samples in blots treated with SAF84. Classical scrapie samples are represented by black symbols, CH1641 by red symbols, and BSE samples by blue symbols. Filled symbols denote natural isolates and open symbols represent the experimental isolates.](10-1215-F2){#F2}

Glycoform profiles, i.e., the relative proportion of diglycosylated, monoglycosylated, and unglycosylated PrP^res^ fragments, have also been reported as a discriminatory criterion for the identification of BSE in sheep ([@R8]*--*[@R10]), as well as when compared with CH1641 ([@R8]*,*[@R10]). With the Istituto Superiore di Sanità WB method ([Figure 2](#F2){ref-type="fig"}, panel B), field scrapie isolates, including CH1641-like isolates, were characterized by a lower diglycosylated-to-monoglycosylated glycoform ratio (0.48:0.35--0.58:0.25) than sheep BSE (0.65:0.25--0.75:0.19) and the natural goat BSE (0.70:0.22).

Conclusions
===========

Because the analysis of PrP^Sc^ from sheep prion isolates by CSSA showed an extremely high conformational stability of BSE samples, we improved the Istituto Superiore di Sanità discriminatory WB by including a pretreatment of brain homogenates with GdnHCl. Our results show that the combined use of 2 independent molecular features, N-terminal cleavage by PK and resistance to denaturation, could indeed differentiate classical scrapie and CH1641-like isolates from small ruminant BSE. Nonetheless, we observed some variability among the CH1641-like samples, either when analyzed by CSSA ([Table 1](#T1){ref-type="table"}) or by the discriminatory WB. As previously reported ([@R12]), the antibody ratios of some CH1641-like samples were close to the cutoff ([Figure 2](#F2){ref-type="fig"}, panel A). Furthermore, the variable conformational stability observed by CSSA was also reflected in the denaturation ratios measured by discriminatory WB, with 2 CH1641-like samples showing a relatively higher resistance to GdnHCl than to all other scrapie samples. Because of the limited number of CH1641-like isolates, further studies are needed to evaluate their effective range of variability.

This variability may be disappointing for discriminatory purposes, but it may also hinder the possible presence of subtle PrP^Sc^ conformational (and possibly strain) variants in CH1641-like isolates. The biologic similarities of CH1641-like samples after transmission to ovine transgenic mice ([@R13]) and voles (U. Agrimi, unpub. data) were worth noting. Nevertheless, CH1641-like isolates induced a certain degree of PrP^Sc^ molecular variability in both rodent models (*13*; U. Agrimi, unpub. data), which might be related to the molecular variability in PrP^Sc^ extracted from sheep brain.

Although based on a limited set of samples, our study supports the notion that CH1641-like isolates can be convincingly discriminated from small ruminant BSE on molecular grounds. Furthermore, the high conformational stability of BSE, when compared with that in classical scrapie, Nor98, and CH1641-like isolates, suggests the potential of the new discriminatory WB here proposed for discriminating BSE from other known small ruminant TSEs.

Supplementary Material
======================

###### Technical Appendix

Provides additional information on the Determination of the SAF84/P4 antibody ratio.
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